Cibc World Markets Corp Exelixis, Inc. Transaction History

Cibc World Markets Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $396,723 - $470,679	19,669 New	19,669 $466,000
Q2 2021 Aug 10, 2021	SELL	$17.95 - $25.56 $601,325 - $856,260	-33,500 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$20.53 - $25.22 $687,755 - $844,870	33,500 New	33,500 $757,000
Q1 2018 May 11, 2018	SELL	$22.15 - $31.89 $5.3 Million - $7.62 Million	-239,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$24.23 - $30.93 $5.79 Million - $7.4 Million	239,100	239,100 $7.27 Million

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

Stay updated on Cibc World Markets Corp with notifications on news.